Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based tool developed at the University of Oregon could help scientists better ...

In contemporary warfare, technology has moved beyond a supporting role to become central to decision-making itself. Recent ...

A single drug can take more than a decade and an estimated $2.6 billion to bring to market, and much of that time is spent ...

GCC leaders say their centres contribute beyond cost arbitrage, and 87% have taken ownership of end-to-end global processes.

At the center of Metis’ AI-driven nanotechnology delivery system is NanoForge, its core platform. It includes a ...

This issue of Transforming Care looks at how employees of health care systems are working to make AI useful while also ...

AI agents and physical AI are no longer abstract risks. They’re changing how routers, switches, OT gear, and cloud paths must ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.